Skip to main content

FORUM MARKETS Inc

For the period ended Dec 31, 2024. Filed Mar 31, 2025.

View on SEC.gov

About this filing

A company's yearly report to the SEC, with audited financial statements. It is the fullest account a company gives of its business, its finances and the risks it sees.

FY2024 · Filed Mar 31, 2025

FRMM$2.82-2.1%Stored close · as of Nov 10, 2026

Extracted filing text, with the paragraph anchors used by the comparison.

See the whole filing, with its images and exhibits
Contents

Consolidated Statements of Changes in Stockholders’ Equity

CONSOLIDATED STATEMENTS OF CHANGES IN STOCKHOLDERS’ EQUITY (DEFICIT)

Series B Preferred Stock · Common Stock · Additional Paid-in · Accumulated Other Comprehensive · Accumulated · Total Stockholders’ Equity
Shares · Amount · Shares · Amount · Capital · Income · Deficit · (Deficit)
Balance - January 1, 2023-$-197,209$20$121,637,966$(2,885,523)$(107,408,545)$11,343,918
Adjustment related to reverse stock split--371(1)---
Shares issued for professional services to directors--4,763-60,624--60,624
Shares issued for professional services to executive chairman--7,126128,564--28,565
Issuance of April 2023 pre-funded and common warrants, net (a)----2,337,706--2,337,706
Shares issued from exercise of April 2023 pre-funded warrants (a)--61,6156111--117
Shares issued in connection with April 2023 Offering (a)--21,0532382,180--382,182
Issuance of August 2023 pre-funded and common warrants, net (b)----2,459,282--2,459,282
Shares issued from exercise of August 2023 pre-funded warrants (b)--207,81420375--395
Shares issued in connection with August 2023 Offering (b)--35,1024245,344--245,348
Issuance of pre-funded and common warrants from Amendment to August 2023 SPA, net----770,923--770,923
Stock-based compensation----2,194,135--2,194,135
Comprehensive loss:--
Net loss------(19,935,112)(19,935,112)
Other comprehensive loss-----(15,816)-(15,816)
Balance - December 31, 2023-$-534,719$54$130,117,209$(2,901,339)$(127,343,657)$(127,733)
(a)Consists of $2,999,882 of gross proceeds from the April 2023 Offering (defined below); gross proceeds of $421,527 are related to common shares issued (with related placement agent fees of $39,343), gross proceeds of $1,233,564 are related to pre-funded warrants issued (with related placement agent fees of $115,134) and gross proceeds of $1,344,791 are related to common warrants issued (with related placement agent fees of $125,516). At the end of the current period, all 61,615 April 2023 pre-funded warrants were exercised for proceeds of $117.
(b)Consists of $2,999,605 of gross proceeds from the August 2023 Offering (defined below); gross proceeds of $272,106 are related to common shares issued (with related placement agent fees of $26,758), gross proceeds of $1,449,470 are related to pre-funded warrants issued (with related placement agent fees of $142,538) and gross proceeds of $1,278,029 are related to common warrants issued (with related placement agent fees of $125,679). At the end of the year, 207,814 August 2023 pre-funded warrants were exercised for proceeds of $395.
Series B Preferred Stock · Common Stock · Additional Paid-in · Accumulated Other Comprehensive · Accumulated · Total Stockholders’
Shares · Amount · Shares · Amount · Capital · Income · Deficit · Equity
Balance - January 1, 2024-$-534,719$54$130,117,209$(2,901,339)$(127,343,657)$(127,733)
Shares issued from exercise of pre-funded warrants related to Amendment to August 2023 Offering--257,50526463--489
Adjustment related to reverse stock split in February 2024--60,8486(6)---
Shares issued in connection with December 2024 Offering--1,200,0001202,572,669--2,572,789
Shares issued from exercise of warrants--950,069952,797,841--2,797,936
Shares issued for settlement of liabilities--174,15817684,654--684,671
Stock based compensation----308,169--308,169
Warrants and Series B Convertible Preferred Stock issued for asset acquisition----4,849,346--4,849,346
Reclassification of Series B Convertible Preferred Stock liability1,000,000100--4,349,900--4,350,000
Deemed dividend from warrant inducement----8,011,510-(8,011,510)-
Comprehensive income (loss):
Net loss------(6,168,177)(6,168,177)
Other comprehensive loss-----(15,579)-(15,579)
Balance - December 31, 20241,000,000$1003,176,999$318$153,691,755$(2,916,918)$(141,523,344)$9,251,911
ContentsView on SEC.gov

The text of this filing, as the company filed it with the SEC, without its images or exhibits. This is not investment advice.